An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis

Justin Jackson(Scholar Rock (United States)), Adam I. Fogel(Scholar Rock (United States)), Mania Kavosi(Scholar Rock (United States)), Abhishek Datta(Scholar Rock (United States)), Frederick C. Streich(Scholar Rock (United States)), Rohan Manohar(Scholar Rock (United States)), Christopher Chapron(Scholar Rock (United States)), George Coricor(Scholar Rock (United States)), Gregory J. Carven(Scholar Rock (United States)), Marcie Wood(Scholar Rock (United States)), Kailyn Looby(Scholar Rock (United States)), Alan Buckler(Harvard University), Samantha B. Nicholls(Massachusetts General Hospital), Francis T. Danehy(Scholar Rock (United States)), Mohammed Qatanani(Scholar Rock (United States)), Thomas Schürpf(Akebia Therapeutics (United States)), Constance J. Martin(Scholar Rock (United States)), Kevin B. Dagbay(Scholar Rock (United States)), Christopher Brueckner(Scholar Rock (United States)), Shaun Cote(Scholar Rock (United States)), Christopher Littlefield(Scholar Rock (United States)), Kaleigh Canonico(Scholar Rock (United States)), Sandeep Kumar(Scholar Rock (United States)), Ajai Pal(Scholar Rock (United States)), Susan Lin(Scholar Rock (United States)), Stefan Wawersik(Brigham and Women's Hospital), Chris Boston(Scholar Rock (United States)), Agatha Zawadzka(Scholar Rock (United States))
Science Signaling
July 9, 2024
Cited by 19


Related Papers